Aa Pharma

What Aa Pharma does

AA Pharma Inc. is a privately held Canadian pharmaceutical company founded in 1989 and headquartered in Vaughan, Ontario. The company specializes in legacy pharmaceuticals — established, off-patent generic medications with documented real-world efficacy and safety profiles — and explicitly positions itself against newer, higher-priced "me-too" alternatives by emphasizing therapeutic equivalence at lower cost. Its portfolio spans more than 50 drugs across cardiovascular, psychiatric, neurological, anti-infective, respiratory, endocrine, and metabolic/bone-health therapeutic areas, with named products including AA-CLOZAPINE, AA-LEVOCARB CR, AA-METHYLPHENIDATE SR, AA-ATENIDONE, AA-DILTIAZ FCT, AA-FENO-MICRO/SUPER, AA-IPRAVENT, AA-RISEDRONATE DR, and AA-THEO LA/ER, among others.

AA Pharma's core technology and product architecture is built around Health Canada-approved generic formulations rather than proprietary drug discovery or AI-driven platforms. The company has built out the AASPIRE Patient Care Network — a mobile-friendly HCP portal that supports online patient disposition/interruption requests, adverse event reporting, quality complaints, and patient drug profile overviews (originally anchored on clozapine REMS-style monitoring) — which functions as a value-added digital layer on top of the legacy drug portfolio rather than as a standalone tech product.

Commercially, AA Pharma operates a wholesale-led distribution model: products are sold to Canadian wholesalers and reach virtually every pharmacy in Canada, with provincial formulary coverage across all 13 provinces and territories. The company reaches prescribers and pharmacists through an HCP-gated product portal requiring professional license authentication, a bilingual (EN/FR) website, and direct customer service (phone, fax, email). End-customers are fragmented Canadian patients, while revenue mechanics flow through a concentrated B2B wholesale channel. No public pricing, revenue, or headcount figures are disclosed.

Name

Aa Pharma

Legal name

AA Pharma Inc.

Website

https://aapharma.ca

Company type

Private

Founded year

1989

Operating status

Operating

Short description

AA Pharma Inc. is a privately held Canadian specialty generic pharmaceutical company, founded in 1989 and headquartered in Vaughan, Ontario. It markets 50+ legacy prescription drugs across cardiovascular, psychiatric, neurological, respiratory, and other therapeutic areas to Canadian pharmacies via national wholesalers, supported by the AASPIRE patient monitoring portal.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Generic pharmaceuticals
• Prescription medications
• Legacy drug formulations
• Cardiovascular generic drugs
• Pharmaceutical wholesale distribution

Headquarters

HQ city

Vaughan

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Prescription Pharmaceutical Sales: AA Pharma generates revenue through the sale of generic prescription medications to wholesalers and pharmacies across Canada. The company offers over 50 drugs in various therapeutic areas including cardiovascular, psychiatric, neurological, anti-infective, and other medication categories. Products are distributed through wholesale channels to reach pharmacies nationwide.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

AA Pharma develops, manufactures, and distributes a portfolio of over 50 legacy generic prescription pharmaceuticals across cardiovascular, psychiatric, neurological, anti-infective, respiratory, endocrine, and other therapeutic areas for the Canadian market. The company focuses on established medications with well-documented efficacy and safety profiles as cost-effective alternatives to newer, more expensive brand-name drugs. Distribution occurs primarily through Canadian wholesalers to pharmacies nationwide, supported by the AASPIRE Patient Care Network monitoring program for healthcare professionals.

Product overview

AA Pharma is a Canadian pharmaceutical company specializing in legacy pharmaceuticals with over 50 drugs across multiple therapeutic areas. The company's product portfolio is centered on established medications with well-documented efficacy and safety profiles, offering cost-effective alternatives to newer, more expensive drugs. The portfolio includes the AASPIRE Patient Care Network as a proprietary monitoring platform for healthcare professionals, complemented by a comprehensive range of prescription pharmaceuticals covering cardiovascular medications (AA-AMILZIDE, AA-ATENIDONE, AA-DILTIAZ FCT, AA-VERAP, AA-METOPROLOL SR), psychiatric/neurological treatments (AA-CLOZAPINE, AA-LEVOCARB CR, AA-METHYLPHENIDATE SR), anti-infectives, and various other therapeutic categories including respiratory (AA-IPRAVENT, AA-THEO LA), metabolic/bone health (AA-RENO-SUPER FCT, AA-RISEDRONATE DR), and hormonal therapies (AA-MEDROXY TABLETS). The company operates through a healthcare professional portal and consumer product site, with products available through wholesalers and pharmacies across Canada.

Differentiator

Problem solved

Functional benefit

Brands

• AASPIRE Patient Care Network: A comprehensive monitoring program designed for patients and healthcare professionals, enabling online requests for dispositions/interruptions, adverse event reporting, and quality complaints. Includes patient drug profile overviews and various resources.

Products and services

• AASPIRE Patient Care Network A comprehensive patient monitoring program designed for healthcare professionals to manage patient drug profiles, perform online requests for dispositions/interruptions, report adverse events and quality complaints, and access educational resources. Features a mobile-friendly dashboard and online portal at www.aaspire.ca. Primarily used for monitoring patients prescribed AA Pharma products such as clozapine.
• AA-CLOZAPINE Clozapine medication available in 25mg, 50mg, 100mg, and 200mg tablet strengths for psychiatric treatment. Distributed under CLOZARIL brand reference. Requires prescription for retail sales. Indicated for treatment-resistant schizophrenia.
• AA-AMILZIDE Combination of amiloride hydrochloride and hydrochlorothiazide 5-50mg tablets for cardiovascular treatment (hypertension and edema). Distributed under MODURET brand reference.
• AA-ATENIDONE Atenolol and chlorthalidone combination tablets available in 50/25mg and 100/25mg strengths for hypertension treatment. Distributed under TENORETIC brand reference.
• AA-DILTIAZ FCT Diltiazem hydrochloride tablets in 30mg and 60mg strengths for cardiovascular treatment (angina and hypertension). Distributed under CARDIZEM brand reference.
• AA-FENO-MICRO / AA-FENO-SUPER FCT Fenofibrate capsules and film-coated tablets in various strengths (67mg, 100mg, 160mg, 200mg) for lipid management. Distributed under LIPIDIL MICRO and LIPIDIL SUPRA brand references.
• AA-IPRAVENT Ipratropium bromide inhalation solution 250 mcg/mL in 20mL and nasal spray 0.06% for respiratory treatment (COPD, asthma, rhinitis). Distributed under ATROVENT brand reference.
• AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN Triple combination of amoxicillin, clarithromycin, and lansoprazole 30mg/500mg/500mg in capsule form for H. pylori treatment (peptic ulcer eradication). Distributed under HP-PAC brand reference.
• AA-LEVOCARB CR Carbidopa and levodopa controlled-release tablets in 100/25mg and 200/50mg strengths for Parkinson's disease treatment. Distributed under SINEMET brand reference.
• AA-MEDROXY TABLETS Medroxyprogesterone acetate tablets in 2.5mg, 5mg, 10mg, and 100mg strengths for hormonal therapy. Distributed under PROVERA brand reference.
• AA-METHYLPHENIDATE SR Methylphenidate hydrochloride sustained-release 20mg tablets for ADHD treatment. Distributed under RITALIN SR brand reference.
• AA-METOPROLOL SR Metoprolol tartrate sustained-release 100mg tablets for cardiovascular treatment (hypertension, angina). Distributed under LOPRESOR SR brand reference.
• AA-RISEDRONATE DR 35 MG Risedronate sodium delayed-release 35mg tablets for osteoporosis treatment. Available in 4-tab and 30-tab pack sizes. Distributed under ACTONEL brand reference.
• AA-THEO LA / THEO ER Theophylline extended-release tablets in 100mg, 200mg, and 300mg strengths for respiratory treatment (asthma, COPD). Distributed under THEO-DUR and UNIPHYL brand references.
• AA-VERAP Verapamil hydrochloride capsules in 80mg and 120mg strengths for cardiovascular treatment (hypertension, angina, arrhythmias). Distributed under ISOPTIN brand reference.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Health Products Stewardship Association (HPSA)minorOthersAA Pharma supports the Health Products Stewardship Association (HPSA) as part of their commitment to responsible medication disposal. HPSA manages Medications Return Programs and Sharps Collection Programs that provide safe and convenient ways for consumers to dispose of unused or expired household medications and medical sharps in an environmentally responsible manner.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Pharmascience Inc. Privately-held Canadian generic pharmaceutical company headquartered in Montreal, manufacturing generic prescription drugs across multiple therapeutic areas for the Canadian and international markets. Closest peer to AA Pharma in terms of private Canadian legacy/generic focus and national distribution.
• Sandoz Canada: Canadian arm of Sandoz (Novartis), the global leader in generic and biosimilar medicines. Directly competes with AA Pharma in generic prescription pharmaceuticals distributed through Canadian wholesalers and pharmacies.
• Mint Pharmaceuticals Inc. Canadian-based generic pharmaceutical company focused on providing affordable generic prescription medications. Similar mid-sized profile to AA Pharma with overlapping therapeutic categories in cardiovascular and central nervous system.
• SteriMax Inc. Canadian specialty pharmaceutical company offering generic and branded injectable and specialty products. Comparable to AA Pharma in its Canadian-market focus and legacy/specialty pharma positioning, with overlapping distribution through Canadian wholesalers.
• Jamp Pharma Group: Canadian pharmaceutical company based in Quebec specializing in generic prescription pharmaceuticals, OTC products, and consumer health. Comparable to AA Pharma in Canadian-market focus and generic prescription pharma manufacturing across multiple therapeutic areas.
• Apotex Inc. Canada's largest generic pharmaceutical manufacturer with a broad multi-therapeutic portfolio distributed nationally through wholesalers and pharmacies. Directly comparable to AA Pharma in business model and product categories, though at substantially larger scale.
• Teva Canada: Canadian subsidiary of Teva Pharmaceutical Industries, one of the world's largest generic drug makers. Competes directly with AA Pharma across multiple therapeutic categories in Canada with similar wholesale and pharmacy distribution.
• Accord Healthcare Inc. Canadian subsidiary of Intas Pharmaceuticals, focused on generic prescription medicines across oncology, cardiology, neurology and other therapeutic areas. Directly comparable to AA Pharma in generic prescription pharma distribution through Canadian wholesalers.

Broad incumbents

• Viatris (Mylan-Upjohn): Global healthcare company formed through the merger of Mylan and Upjohn, offering an extensive portfolio of generic and biosimilar medicines across major therapeutic areas. Overlaps with AA Pharma in generic pharmaceuticals distributed in Canada.
• Bausch Health Companies Inc. Canadian-headquartered (Laval, Quebec) global pharmaceutical company with diversified branded generic, branded pharma, and over-the-counter product lines. Comparable as a Canadian-headquartered pharma with broad therapeutic coverage, though much larger and more diversified than AA Pharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aa Pharma